The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine

(2012) Ditte Dencker et al.   PSYCHOPHARMACOLOGY

Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks

(2011) Amy F.T. Arnsten   BIOLOGICAL PSYCHIATRY

Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor

(2011) Anders Fink-Jensen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Involvement of a Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors in the Antipsychotic-like Effects of the M1/M4 Preferring Muscarinic Receptor Agonist Xanomeline

(2011) D. Dencker et al.   JOURNAL OF NEUROSCIENCE

M5 Muscarinic Receptors Mediate Striatal Dopamine Activation by Ventral Tegmental Morphine and Pedunculopontine Stimulation in Mice

(2011) Stephan Steidl et al.   PLoS One

Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice

(2009) Lene S. Schmidt et al.   PSYCHOPHARMACOLOGY

Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice

(2009) Morgane Thomsen et al.   PSYCHOPHARMACOLOGY

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

(2008) Anantha Shekhar et al.   AMERICAN JOURNAL OF PSYCHIATRY

Heterooligomers of the muscarinic receptor and G proteins purified from porcine atria

(2008) Amy W.-S. Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia

(2008) W. Y. Chan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

(2008) Neal R. Swerdlow et al.   PSYCHOPHARMACOLOGY